Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 3622 Records) |
| Query Trace: Neoplasms and KRAS[original query] |
|---|
| Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108051. S Berenice Urtecho, Leonardo Provenzano, Andrea Spagnoletti, Achille Bottiglieri, Chiara Pircher, Giacomo Massa, Caterina Sposetti, Claudia Proto, Marta Brambilla, Mario Occhipinti, Laura Mazzeo, Teresa Beninato, Rita Leporati, Claudia Giani, Chiara Cavalli, Roberta Serino, Marco Meazza Prina, Anna Bassetti, Vincenzo Nasca, Rosa Maria di Mauro, Alice Abate, Sara Manglaviti, Andra Diana Dumitrascu, Giorgia Di Liberti, Teresa Serra Cassano, Monica Ganzinelli, Sulin Wu, Marina Chiara Garassino, Filippo G M de Braud, Giuseppe Lo Russo, Arsela Prel |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma. Molecular diagnosis & therapy 2024 12 . E Jutten, L C L T van Kempen, G F H Diercks, B L van Leeuwen, S Kruijff, K P Weve |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108068. Mingying Wu, Na Zhou, Mei Guan, Yingyi Wang, Yuzhou Wa |
| Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database. Current issues in molecular biology 2024 12 46 (12): 14476-14486. Shuhei Suzuki, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, Tadahisa Fukui, Takashi Yoshio |
| Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer. Current issues in molecular biology 2024 12 46 (12): 13617-13646. B?a?ej Ochman, Anna Kot, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Dominika Koszewska, Dorota Hudy, Monika Szrot, Jerzy Piecuch, Dariusz Waniczek, Zenon Czuba, El?bieta ?wi?tochows |
| Unraveling the Genetic Landscape of Langerhans Cell Histiocytosis in Korean Patients: Comprehensive Insights from Mutational Profiles and Clinical Correlations. Cancer research and treatment 2024 12 . Kyung-Nam Koh, Ha Ra Jun, Ji-Young Lee, Ji Young Kim, Su Hyun Yoon, Young Kwon Koh, Sung Han Kang, Hyery Kim, Ho Joon Im, Sung-Min Ch |
| Predictive role of [F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients. EJNMMI reports 2024 12 8 (1): 42. Magdi A Ali, Omar Shebl Zahra, Mohmed I Morsi, Mohamed M El Safwany, Shaymaa Essam El Fe |
| Clinical and genetic drivers of oligo-metastatic disease in colon cancer. Neoplasia (New York, N.Y.) 2024 12 60 101111. Alessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, Annabella Di Mauro, Antonella Di Carlo, Monica Ianniello, Francesco Sabbatino, Rosa Castiello, Francesca Del Peschio, Marco Cascella, Francesco Perri, Maurizio Capuozzo, Nicola Martucci, Edoardo Mercadante, Valentina Borzillo, Rossella Di Franco, Francesco Izzo, Vincenza Granata, Carmine Picone, Antonella Petrillo, Massimiliano Berretta, Salvatore Stilo, Luca Tarotto, Anna Chiara Carratù, Gerardo Ferrara, Madhura Tathode, Alessia Maria Cossu, Marco Bocchetti, Michele Caraglia, Guglielmo Nasti, Giovanni Savare |
| IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY. Experimental oncology 2024 12 46 (3): 221-227. G Gerashchenko, R Gulkovskyi, N Melnichuk, N Hryshchenko, T Marchyshak, O Mankovska, A Bezverkhiy, I Kotuza, L Rosha, A Kotuza, Z Tkachuk, V Kashuba, M Tuka |
| A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108065. Ioannis Zerdes, Caroline Kamali, Berglind Johannsdottir, Miriam Blasi, Christin Assmann, Daniel Kazdal, Albrecht Stenzinger, Marcus Skribek, Simon Ekman, Petros Christopoulos, Georgios Tsakon |
| Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. Translational cancer research 2024 12 13 (11): 6235-6245. Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P De |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer. The Journal of molecular diagnostics : JMD 2024 12 . Riccardo Adorisio, Davide Ciardiello, Alessandra Rappa, Lorenzo Gervaso, Gloria Pelizzari, Laura Marinucci, Nicola Fusco, Maria Giulia Zampino, Nicola Fazio, Konstantinos Venetis, Elena Guerini-Roc |
| Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Add |
| Colorectal Cancer and Its Microenvironment: A Brief Review. Medical journal of the Islamic Republic of Iran 2025 1 38 108. Nauryzbay M Imanbayev, Arip K Koyshybaev, Nurgul M Kereyeva, Marzhan A Aitmagambetova, Azamat B Zharylgap |
| Value of the combination of intraepithelial tumor-infiltrating lymphocyte density and the heterogeneity of density as a prognostic marker in stage III colorectal cancers. Histology and histopathology 2025 1 18864. Hye-Yeong Jin, Lingyan Jin, Seung Yeon Yoo, Nam-Yun Cho, Jeong Mo Bae, Jung Ho Kim, Hye Seung Lee, Gyeong Hoon Ka |
| [Mutations and their consequences in the development of pancreatic cancer]. Postepy biochemii 2025 1 70 (4): 490-496. Przemys?aw Panek, Jaros?aw Rachuna, ?ukasz Madej, Ryszard Tomasiuk, Aleksandra Jezela-Stan |
| Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2025 1 5 (6): 1435-1449. Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, Hélène Blons, Rym BenDhiab, Laure Gibault, Elizabeth Fab |
| Glecirasib in KRAS-mutated nonsmall-cell lung cancer: a phase 2b trial. Nature medicine 2025 1 . Yuankai Shi, Jian Fang, Ligang Xing, Yu Yao, Jian Zhang, Lian Liu, Yongsheng Wang, Changlu Hu, Jianping Xiong, Zhihua Liu, Runxiang Yang, Zhen Wang, Enfeng Zhao, Mengzhao Wang, Yanqiu Zhao, Kejing Tang, Zhihua Li, Zhengbo Song, Yongsheng Li, Wu Zhuang, Bo Jin, Ying Cheng, Yanping Hu, Yanhong Gu, Lin Wu, Rui Ma, Qitao Yu, Yan Yu, Jun Zhao, Hui Zhao, Dongqing Lv, Yanhong Shang, Puyuan Xing, Jin Zhou, Xingya Li, Zhe Liu, Zhaoxia Dai, Guohao Xia, Xueqin Chen, Yi Ba, Chunmei Bai, Qingshan Li, Guangyu An, Weiguo Hu, Yinxiang Wang, Andrea Wang-Gillam, Yuli Ding, Qiao Li, Zhiyue R |
| [An assay for the rapid detection of EGFR and KRAS gene mutation in cancer]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2025 1 54 (1): 75-77. S F Wu, M C Sun, L L Zeng, Y Y Liu, K M Li, X Ze |
| Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2025 1 1-13. Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G White, John Paul Shen, Eduardo Vilar, Christine Parseghian, Arvind Dasari, Van Karlyle Morris, Ryan Huey, Michael J Overman, Robert Wolff, Kanwal P Raghav, Jason Willis, Kristin Alfaro, Andy Futreal, Y Nancy You, Scott Kope |
| ASO Author Reflections: Preoperative Evaluation of KRAS Gene Mutations in Rectal Cancer. Annals of surgical oncology 2025 1 . Yajiao Gan, Qiping Hu, Qingling Shen, Peng Lin, Qingfu Qian, Minling Zhuo, Ensheng Xue, Zhikui Ch |
| Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer science 2025 1 . Yuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, Mayu Takeda, Makoto Sumitomo, Seiji Yamada, Gaku Inaguma, Yusuke Omura, Yeongcheol Cheong, Yosuke Kobayashi, Masaya Nakauchi, Junichiro Hiro, Koji Masumori, Koki Otsuka, Hiroshi Nishihara, Koichi Suda, Hideyuki Saya, Tetsuya Takimo |
| Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer. Ecancermedicalscience 2025 1 18 1797. Daniela Rodríguez-Carrascal, Rafael Puche, Mary Acosta, Carlos Darío Ramír |
| Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report. Frontiers of medicine 2025 1 . Xiaotong Qiu, Liangkun You, Chongwei Wang, Jin She |
| TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study. Cancer medicine 2025 1 14 (2): e70533. Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin |
| Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study. European journal of cancer (Oxford, England : 1990) 2025 1 217 115224. Hsin-Yi Wang, Wei-Yu Liao, Chao-Chi Ho, Shang-Gin Wu, Ching-Yao Yang, Chia-Lin Hsu, Yen-Ting Lin, James Chih-Hsin Yang, Jin-Yuan Sh |
| Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer. Cancer science 2025 1 . Jianjiong Li, Chunnian Wang, Changshun Yang, Hua Bao, Ningyou Li, Xianqiang Huang, Wei Gong, Xinyue Hong, Jiani C Yin, Jiaohui Pang, Meifu Gan, Danping Yu |
- Page last reviewed:Feb 1, 2024
- Content source: